User menu

An Evaluation of the Safety of the Beta-modulator Cicloprolol in Chronic Heart-failure

Bibliographic reference Cocco, G. ; Alfiero, R. ; Pouleur, H.. An Evaluation of the Safety of the Beta-modulator Cicloprolol in Chronic Heart-failure. In: Clinical Cardiology (Hoboken) : an indexed and peer-reviewed journal for advances in the treatment of cardiovascular disease, Vol. 15, no. 1, p. 38-42 (1992)
Permanent URL
  1. Bristow, N Engl J Med, 307, 205 (1982)
  2. Bristow M. R., Ginsburg R., Umans V., Fowler M., Minobe W., Rasmussen R., Zera P., Menlove R., Shah P., Jamieson S., Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down- regulation in heart failure, 10.1161/01.res.59.3.297
  3. Summers R. J., Molnaar P., Russell F., Elnatan J., Jones C. R., Buxton B. F., Chang V., Hambley J., Coexistence and localization of  1- and  2-adrenoceptors in the human heart, 10.1093/eurheartj/10.suppl_b.11
  4. Brodde O.-E., Zerkowski H.-R., Borst H. G., Maier W., Michel M. C., Drug- and disease-induced changes of human cardiac  1- and  2-adrenoceptors, 10.1093/eurheartj/10.suppl_b.38
  5. Fowler M. B., Cardiac adrenoceptors in the failing heart: effect of intervention, 10.1093/eurheartj/11.suppl_a.13
  6. The Xamoterol in Severe Heart Failure Group, Lancet, 336, 1 (1990)
  7. Kupper W., Erlemeier H.-H., Bleifeld W., Sympathetic modulation in practice: the German clinical experience, 10.1093/eurheartj/11.suppl_a.19
  8. Pouleur H., Hanet C., Rousseau M. F., Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction, 10.1093/eurheartj/11.suppl_a.33
  9. Ollivier J. P., Ricordei I., Bayon P., Popelard P., Moyse D., de Bourayne J., Dupont C., Droniou J., Effect of xamoterol on haemodynamics and plasma catecholamines in chronic heart failure, 10.1093/eurheartj/11.suppl_a.59
  10. Kenakin, Circ Res, 59, 90 (1986)
  11. Fowler, Circulation, 82, III (1990)
  12. Carcone B, Grosset A, Cazor JL, Hicks P: Cicloprolol (hydrochloride) (SL 75.177-10). Clinical Investigators Manual, Synthélabo Recherche (December 1988)
  13. Carcone B, Claudel S: Essai comparatif entre le Cicloprolol (SL 75.177-10) à doses croissantes et un placebo chez des malades souffrant d'angor stable (Etude Cidora). Synthélabo, Int Rept M 3302 88 016 (1988)
  14. Buxton, Med Care, 19, 787 (1985)
  15. Bulpitt, Cardiovas Med, 10, 3 (1991)
  16. Hills M., Armitage P., The two-period cross-over clinical trial., 10.1111/j.1365-2125.1979.tb05903.x
  17. Lee, Cardiol Clin, 7, 171 (1989)
  18. Engelmeier, Circulation, 73, II (1986)
  19. Heilbrunn, Circulation, 76, IV (1987)